Diabetes

In patients at risk for type 2 diabetes, diet and exercise have beneficial effects on regulating glucose levels beyond those associated with weight loss.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers clinicians may face to initiating insulin use.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses how pharmacists can help their patients who take insulin.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers patients may have to starting insulin.

Taking statins associated with greater likelihood of developing diabetes with complications.

Even healthy adults taking statins are 87% more likely to develop diabetes.

Although metformin can help prevent diabetes onset in those at high risk, the medication is rarely prescribed for this purpose.

Gene may help identify clue to separation of overactive and underactive immune activity.

Novel pathway regulating immune cell movement may help eliminate debilitating effects of several serious diseases.

Meter can test glucose levels within 5 seconds.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, talks about the benefits and risks of insulin therapy.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, describes some ways in which pharmacists can help patients with type 2 diabetes mellitus manage their disease.

Women with a history of depression may have greater odds of developing gestational diabetes.

Record number of orphan drugs approved in 2014.

Abbott's new blood glucose meter is now widely available OTC without insurance co-pays.

Treatments found to improve glycemic control.

Treatment found to lower blood sugar levels in obese mice.

The lack of generic insulin may keep patients from using the medicine, even though they risk life-threatening complications, new research from Johns Hopkins University School of Medicine suggests.

An FDA advisory panel recommends adding a warning about the potential risk for heart failure to the labels of saxagliptin (Onglyza), saxagliptin/metformin (Kombiglyze), and alogliptin (Nesina).

The FDA refused to approve Novo Nordisk's ultra-long-acting insulin treatments 2 years ago.

The FDA has approved GlaxoSmithKline's Tanzeum (albiglutide) subcutaneous injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Rarely is a prescription written for U-500 insulin that doesn't require clarification from a pharmacist.

Although glyburide is commonly prescribed for gestational diabetes mellitus, the drug's use among pregnant women may put newborns at greater risk for complications.

The FDA refused to approve the ultra-long-acting insulin treatments 2 years ago.

Earlier detection could lead to improved disease management.

Diabetes mellitus diagnoses are soaring in numbers, with the elderly population disproportionately affected. The APhA featured a case-based presentation at its 2015 annual meeting in San Diego, CA, that discussed diabetes management's complexities in older adults.

States that expanded Medicaid coverage under the Affordable Care Act have seen a 23% increase in the number of newly diagnosed diabetes patients.

The FDA has approved a new treatment for 1 of the most common diabetic eye diseases.